COVID-19 Vaccine - Outlook & Opportunities for Modelling

At theNational Collaborating Centre for Infectious Diseases, we specialize in forging connections between those who generate and those who use infectious disease public health knowledge. From policy to practice, we’re able to build bridges between those with infectious disease questions, those with answers, and those in a position to act on the evidence. One of six National Collaborating Centres for Public Health funded by the Public Health Agency of Canada, our host organization is the University of Manitoba.AuCentre de collaboration nationale des maladies infectieuses, nous sommes les experts de l’établissement de liens entre ceux qui génèrent les connaissances sur les maladies infectieuses, en termes de santé publique, et ceux qui utilisent ce savoir. Des politiques aux pratiques, nous avons la capacité de jeter des ponts entre ceux qui se posent des questions au sujet des maladies infectieuses, ceux qui peuvent répondre à ces questions, et ceux qui sont en mesure de passer concrètement à l’action en se fondant sur les données probantes. CCNMI est un des six centres de collaboration nationale financés par l’Agence de la santé publique du Canada. Notre organisation hôte est l’Université du Manitoba.

NCCID - CCNMI

Join NCCID for another event in the interdisciplinary webinar series: Synergies in COVID-19 Vaccine Outlook & Opportunities for Modelling.

<p>The Synergies Series harnesses the knowledge of experts from several disciplines and nations. Collaborators share research evidence, context-based insights, information on data availability, and practical tools to develop better infectious disease models and evidence-based public health policies for the control of infectious diseases. Together, participants raise questions of interest to public health that modelling can contribute to. The series begins with topics on COVID-19, with potential to grow. </p>

<h3>SYNOPSIS</h3><p>Immunization by vaccine is one of the most successful public health interventions for the prevention and control of both endemic infectious diseases and emerging pathogens. However, the full cycle of vaccine development, from the research phase through distribution and administration in populations, is generally a staged, complicated and expensive endeavour. This becomes even more challenging in the context of a pandemic, since a safe and effective vaccine is needed in the shortest time possible. The COVID-19 pandemic has prompted new interest in how simulation and modelling might fast-track vaccine development. The value of these quantitative approaches could be realized at various stages of vaccine development—from the investigation of pathogen mechanisms in pre-clinical trials to estimation of the effectiveness of individual vaccines. Dialogue with modellers can help identify the greatest needs and opportunities.  </p><p>Dr. Joanne Langley, CIHR – GlaxoSmithKline Chair in Pediatric Vaccinology and professor in the Faculty of Medicine at Dalhousie University, presents an overview of current vaccine development for COVID-19. Her presentation highlights the biological technologies involved in front-running vaccine candidates, updates on clinical efficacy trials, and potential strategies on vaccine prioritization and allocation for the current pandemic that could be considered in models.  Dr. Langley draws from experience as a clinician, in clinical vaccine research and service on several immunization advisory bodies. </p>

<h3>ACCESS INSTRUCTIONS</h3><p>Prior to the event, please ensure you <a href="https://helpx.adobe.com/adobe-connect/connect-downloads-updates.html" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">download the Adobe Connect App</a>.</p><p>You may test the compatibility of your computer with Adobe Connect software <a href="https://na1cps.adobeconnect.com/common/help/en/support/meeting_test.htm" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">here</a>. </p><p><strong>To access the webinar: </strong></p><ul><li>Click the “access link”, below.</li><li>Using the ‘Guest’ menu option, type your full name into the text box provided. </li><li>Click ‘Enter Room’ to open the webinar room. </li><li>Choose the option ‘Open in Application’ (not the option to open in a browser)</li><li>You may be prompted to download a plugin prior to opening the application.</li><li>Upon opening the Adobe Connect App, you may be prompted to paste the access link into a space provided.</li><li>If you arrive early, you will see a message that the event is ‘on hold’.</li><li>As you enter the webinar room, a tutorial or ‘tips’ window appears. When you close that window, the webinar room will be visible.</li><li>Note that audio is configured for ‘Listen only’; participants should hear the event through computer speakers, but microphones are muted. </li></ul><p><strong>Access Link:</strong> <a href="http://nccid.adobeconnect.com/rs47zi2j00t0/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">http://nccid.adobeconnect.com/rs47zi2j00t0/</a></p>

<h3><strong>SPEAKER BIO</strong></h3><p>Dr. Joanne Langley, MD, MSc (Clinical Epidemiology), RCPSC (Pediatrics, Infectious Diseases), is a pediatric infectious disease physician in the Department of Pediatrics and is cross-appointed in the Department of Community Health and Epidemiology in the Faculty of Medicine. She is based at the IWK Health Centre and the Canadian Centre for Vaccinology. She conducts studies on the prevention of infectious diseases using vaccines, from phase 1 (first in humans) through to efficacy trials (phase 3) and post-marketing studies of how well vaccines work when they are used in immunization programs (phase 4). These studies are done with collaborators in public health, industry, universities, and non-governmental organizations. Dr. Langley’s work also focuses on vaccine policy and evidence-based decision making in immunization programs. She is a member of the COVID-19 Science Expert Panel, and of the Expert Group on Health Systems of the Chief Science Advisor of Canada, and a former member of the Canadian Task Force on Preventive Health Care and Canada’s National Advisory Committee on Immunization (Chair, 2007-2011). She is an active investigator in the Canadian Immunization Research Network and leads its Clinical Trials Network (CTN).</p>

Our {communityGuidelinesLink} describe the sort of content we prohibit on Eventbrite. If you suspect an event may be in violation, you can report it to us so we can investigate.

To report other categories of prohibited or illegal content, submit {link}

COVID-19 Vaccine - Outlook & Opportunities for Modelling

More events from NCCID - CCNMI

Discover more events from NCCID - CCNMI, from Health to other experiences you might love.

Still looking for the right event?

Explore all online events to browse and filter by date, category, and more.

COVID-19 Vaccine - Outlook & Opportunities for Modelling

More events from NCCID - CCNMI

Discover more events from NCCID - CCNMI, from Health to other experiences you might love.

More Health events

Browse more Health events with different dates, prices, and formats to find your next great experience.

Still looking for the right event?

Explore all online events to browse and filter by date, category, and more.